HEART – DISEASES – AUSTRALIA

How we die in Australia

roymorgansocial Leave a comment

Original article by Shane Wright
The Age – Page: Online : 11-Oct-24

Data from the Australian Bureau of Statistics shows that the nation recorded a total of 183,131 deaths in 2023. This is more than four per cent lower than the previous calendar, which is primarily due to a sharp fall in the number of deaths from COVID-19. The number of deaths from heart disease – which has been the biggest cause of death in Australia for at least six decades – fell to 16,922. In contrast, the number of deaths from dementia and Alzheimer’s disease rose to 16,685; Lauren Moran from the ABS says current trends suggest that this will become the leading cause of death in Australia in coming years. She cities factors such as the nation’s ageing population and improvements in medical care and treatment.

CORPORATES
AUSTRALIAN BUREAU OF STATISTICS

Mesoblast falls 42pc as investors lose heart

roymorgansocial Leave a comment

Original article by Jessica Gardner, James Thomson
The Australian Financial Review – Page: 13 & 18 : 15-Jun-16

The market capitalisation of Australian biotechnology group Mesoblast has fallen to $A750m following a 42.2 per cent fall in its share price on 14 June 2016. The stock closed at a seven-year low of $A1.11 after Teva Pharmaceutical Industries advised that it will not finance the final round of clinical trials for Mesoblast’s stem-cell treatment for heart failure. Mesoblast had cash reserves of around $US100m at the end of the March quarter, and CEO Silviu Itescu is confident that the group can secure funding partners before its cash reserves are exhausted.

CORPORATES
MESOBLAST LIMITED – ASX MSB, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, CEPHALON INCORPORATED, CANACCORD GENUITY (AUSTRALIA) LIMITED